← Leaderboards
George Sigal
Meso Scale Diagnostics, Llc
$5,753,709
Attributed
$5,753,709
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2017–21$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,753,709 · 1
By mechanism
N01$5,753,709 · 1
Top collaborators
No co-investigators on record.
Most similar at Meso Scale Diagnostics, Llc
Same institution · by research overlap
- George B Sigal$9,066,403
- Anu Mathew$3,620,160
- Martin Stengelin$5,846,689
- John H Kenten$1,630,205
- Jeff D Debad$1,214,583
Others in their field
Other Emerging Leaders on “Biological Markers”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,644,754
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,375,181
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,483,553
- Leonard Freedmand · Leidos Biomedical Research, Inc.$64,555,721
- Yunda Huang · Fred Hutchinson Cancer Center$54,118,126
- Susan Abushakra · Alzheon, Inc.$50,765,244
Research focus
Biological MarkersBaseBiodosimetryRadiationRadiation Absorbed DoseAlgorithmsDevicesSamplingTriageEmergency SituationValidationBiomarker PanelImmunoassayMass CasualtyBloodNuclear RadiologyPlasmaProgramsPerformanceNuclear AccidentsMeasurementAntibodiesCollaborationsCovid-19
Grant awards (5)
HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY$112,946
N01 · FY2021 · AI · contact PI
COVID 19 Supplemental work: HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY$1,499,726
N01 · FY2020 · AI · contact PI
HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY$730,677
N01 · FY2019 · AI · contact PI
HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY$1,452,037
N01 · FY2018 · AI · contact PI
HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY$1,958,323
N01 · FY2017 · AI · contact PI